Prepare common size balance sheets for 2019 and 2018

for 2019 and 2018

Consolidated Balance Sheet Merck & Co., Inc. and Subsidiaries December 31 ($ in millions except per share amounts) 2018 2017 $ 7,965 $ 6,092 8992,406 7,071 6,873 Assets Current Assets Cash and cash equivalents Short-term investments Accounts receivable (net of allowance for doubtful accounts of $119 in 2018 and $159 in 2017) Inventories (excludes inventories of $1.417 in 2018 and $1,187 in 2017 classified in Other assets - see Note 7) Other current assets Total current assets Investments Property, Plant and Equipment (at cost) Land Buildings Machinery, equipment and office furnishings Construction in progress 5,440 4,500 25,875 6,233 5,096 4.299 24,766 12,125 Less: accumulated depreciation 333 11,486 14,441 3,355 29,615 16,324 13,291 18,253 11,431 7,554 S 82.637 365 11,726 14,649 2,301 29,041 16,602 12,439 18,284 14,183 6,075 S 87.872 Goodwill Other Intangibles, Net Other Assets $ $ Liabilities and Equity Current Liabilities Loans payable and current portion of long-term debt Trade accounts payable Accrued and other current liabilities Income taxes payable Dividends payable Total current liabilities Long-Term Debt Deferred Income Taxes Other Noncurrent Liabilities Merck & Co., Inc. Stockholders' Equity Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2018 and 2017 Other paid-in capital Retained earnings Accumulated other comprehensive loss 5,308 3,318 10,151 1,971 1,458 22,206 19,806 1,702 12,041 3,057 3,102 10,427 708 1,320 18,614 21,353 2.219 11,117 1,788 38,808 42,579 (5,545) 77,630 1,788 39,902 41,350 (4,910) 78,130 Less treasury stock, at cost: 984,543,979 shares in 2018 and 880,491,914 shares in 2017 Total Merck & Co., Inc. stockholders' equity Noncontrolling Interests Total equity 50,929 43,794 26,701 34,336 181 233 26,88234,569 $ 82,637 $ 87,872 Consolidated Balance Sheet Merck & Co., Inc. and Subsidiaries December 31 ($ in millions except per share amounts) 2019 2018 $ $ 9,676 774 7,965 899 6,778 7,071 5,978 Assets Current Assets Cash and cash equivalents Short-term investments Accounts receivable (net of allowance for doubtful accounts of $86 in 2019 and $119 in 2018) Inventories (excludes inventories of $1,480 in 2019 and $1,417 in 2018 classified in Other assets - see Note 7) Other current assets Total current assets Investments Property, Plant and Equipment (at cost) Land Buildings Machinery, equipment and office furnishings Construction in progress 5,440 4,277 4,500 27,483 25,875 1,4696,233 Less: accumulated depreciation 343 333 11,989 11,486 15,394 14,441 5,013 3,355 32,73929,615 17,686 16,324 15,053 13,291 19,425 18,253 14,196 13,104 6,771 5,881 $ 84,397 $ 82,637 Goodwill Other Intangibles, Net Other Assets $ $ Liabilities and Equity Current Liabilities Loans payable and current portion of long-term debt Trade accounts payable Accrued and other current liabilities Income taxes payable Dividends payable Total current liabilities Long-Term Debt Deferred Income Taxes Other Noncurrent Liabilities Merck & Co., Inc. Stockholders' Equity Common stock, $0.50 par value Authorized - 6,500,000,000 shares Issued - 3,577,103,522 shares in 2019 and 2018 Other paid-in capital Retained earnings Accumulated other comprehensive loss 3,610 3,738 12,549 736 1,587 22,220 22,736 1,470 11,970 5,308 3,318 10,151 1,971 1,458 22,206 19,806 1,702 12,041 1,788 39,660 46,602 (6,193) 81,857 1,788 38,808 42,579 (5,545) 77,630 Less treasury stock, at cost: 1,038,087,496 shares in 2019 and 984,543,979 shares in 2018 Total Merck & Co., Inc. stockholders' equity Noncontrolling Interests Total equity 55,950 25,907 94 26,001 $ 84,397 50,929 26,701 181 26,882 $ 82,637